Genetic Engineering News and Research

RSS

Journal articles on yoga therapy increase 3-fold in last 10 years

During the last 10 years, the number of articles in peer-reviewed journals worldwide about clinical trials of yoga therapy to alleviate disease-related symptoms increased 3-fold. This large-scale analysis of published research studies spanning 46 years, 29 countries, and more than 28,000 study participants is published in The Journal of Alternative and Complementary Medicine, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.

18 Aug 2015

NBTY signs agreement to acquire Dr. Organic

NBTY, Inc., a global leader in vitamins, nutritional supplements and sports nutrition, today announced that it has entered into an agreement to acquire Dr. Organic, a leading naturally inspired skincare line in the UK. The deal is subject to customary closing conditions, and is expected to close later this year.

17 Aug 2015

Opioids produced by yeast; revealing the potential for cheaper pain relief

Researchers at Stanford University have genetically engineered yeast so it produces hydrocodone, a semi-synthetic opioid analgesic used in the United States for relief of moderate to severe pain.

14 Aug 2015

Non-invasive diagnostic imaging can rule out CAD in about 50% of women with atypical chest pain

Non-invasive diagnostic imaging can rule out coronary artery disease (CAD) in about 50% of women with atypical chest pain who are at relatively low risk for CAD, while exposing them to only a modest dose of radiation.

13 Aug 2015

JAYAO article highlights benefits and risks of adolescent sibling stem cell donation

A sibling may often be the best match for a patient who needs a stem cell transplant, but especially for adolescent donors, who are at a vulnerable age, factors such as the responsibility to donate versus a perception of free choice and the potential for anxiety and guilt in the face of complications or poor outcomes demand careful consideration.

12 Aug 2015

CRI to honor three scientists for contributions to immunology and cancer immunotherapy research

The Cancer Research Institute, a nonprofit organization dedicated to fueling the discovery and development of immunotherapies for all forms of cancer, will bestow its highest honors on three scientists who have made fundamental contributions to the fields of immunology and cancer immunotherapy.

10 Aug 2015

Experimental Ebola virus vaccine protects cynomolgus macaques against current EBOV outbreak strain

National Institutes of Health scientists report that a single dose of an experimental Ebola virus (EBOV) vaccine completely protects cynomolgus macaques against the current EBOV outbreak strain, EBOV-Makona, when given at least seven days before exposure, and partially protects them if given three days prior.

7 Aug 2015

Scientists develop biosensor to measure abnormal activity of cell 'fuel' carrier

To be able to function, cell mitochondria import "fuel" using a carrier, the Mitochondrial Pyruvate Carrier (MPC). In order to determine whether the MPC is still functional in malignant cells, the team of Professor Jean-Claude Martinou, at the University of Geneva, Switzerland, has just developed a biosensor to measure its live activity.

7 Aug 2015

NFIX protein drives NSC differentiation toward oligodendrocytes

An international team of researchers has shown that NFIX, a protein that regulates neuronal stem cell activity (NSC), also has a role in driving NSC differentiation toward oligodendrocytes, a type of glial cell. These cells produce the myelin that surrounds and protects neurons.

7 Aug 2015

University of Zurich professor recognized with 2015 Vallee Young Investigator Award

Martin Jinek, a professor at the University of Zurich's Department of Biochemistry, was presented with the 2015 Vallee Young Investigator Award. The international prize is awarded to young researchers for outstanding achievements in biomedicine and carries USD 250,000 in prize money.

6 Aug 2015

New biosensors detect efficient microbial workers that produce chemical, pharmaceutical commodities

Super productive factories of the future could employ fleets of genetically engineered bacterial cells, such as common E. coli, to produce valuable chemical commodities in an environmentally friendly way.

5 Aug 2015

Vaccine containing virus-like nanoparticles could be novel treatment option for RSV

A vaccine containing virus-like nanoparticles, or microscopic, genetically engineered particles, is an effective treatment for respiratory syncytial virus (RSV), according to researchers at Georgia State University.

4 Aug 2015

Scientists produce functional liver cells from human embryonic and genetic engineered stem cells

The liver plays a critical role in human metabolism. As the gatekeeper of the digestive track, this massive organ is responsible for drug breakdown and is therefore the first to be injured due to overdose or misuse. Evaluating this drug-induced liver injury is a critical part of pharmaceutical drug discovery and must be carried out on human liver cells. Regretfully, human liver cells, called hepatocytes, are in scarce supply as they can only be isolated from donated organs.

31 Jul 2015

Researchers uncover master regulators that govern the fate of TFH cells

Follicular helper Tcells (TFH cells), a rare type of immune cell that is essential for inducing a strong and lasting antibody response to viruses and other microbes, have garnered intense interest in recent years but the molecular signals that drive their differentiation had remained unclear.

31 Jul 2015

Novel 3D human skin tissue model could help detect presence of known skin sensitizers in medical device extracts

New research shows that exposing a 3D human skin tissue model to extracts of medical device materials can detect the presence of sensitizers known to cause an allergic response on contact in some individuals. Conventional skin sensitization testing of medical devices relies on animal testing, whereas human skin models could replace animal methods, according to an article in the new journal Applied In Vitro Toxicology, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.

30 Jul 2015

New study reports creation of genetic porcine model of cancer

With many types of cancers, early detection offers the best hope for survival. However, research into new early-detection screenings, as well as possible interventional radiology and surgical treatments, has been hindered by the lack of a large animal model that would accurately reflect the types of cancers seen in human cells.

30 Jul 2015

Study: GMO labeling would not scare consumers from buying food products with GMO ingredients

A new study released just days after the U.S. House passed a bill that would prevent states from requiring labels on genetically modified foods reveals that GMO labeling would not act as warning labels and scare consumers away from buying products with GMO ingredients.

30 Jul 2015

New type of mycovirus can cause aspergillosis in humans

Researchers, led by Dr Robert Coutts, Leverhulme Research Fellow from the School of Life and Medical Sciences at the University of Hertfordshire, and Dr Ioly Kotta-Loizou, Research Associate at Imperial College, have discovered a completely novel type of mycovirus.

29 Jul 2015

Researchers develop dynamic functional mouse model for lung injury repair

Researchers at Children's Hospital Los Angeles and The Saban Research Institute of CHLA have created a dynamic functional mouse model for lung injury repair, a tool that will help scientists explain the origins of lung disease and provide a system by which new therapies can be identified and tested.

29 Jul 2015

Innovative approach to treating AAT deficiency

Researchers have demonstrated the feasibility of delivering an RNA that encodes for the protein alpha-1-antitrypsin (AAT)--which is missing or nonfunctional in the genetic disorder AAT deficiency--into cells in the laboratory, enabling the cells to produce highly functional AAT.

28 Jul 2015

Genetic Engineering News and Research

Journal articles on yoga therapy increase 3-fold in last 10 years

NBTY signs agreement to acquire Dr. Organic

Opioids produced by yeast; revealing the potential for cheaper pain relief

Non-invasive diagnostic imaging can rule out CAD in about 50% of women with atypical chest pain

JAYAO article highlights benefits and risks of adolescent sibling stem cell donation

CRI to honor three scientists for contributions to immunology and cancer immunotherapy research

Experimental Ebola virus vaccine protects cynomolgus macaques against current EBOV outbreak strain

Scientists develop biosensor to measure abnormal activity of cell 'fuel' carrier

NFIX protein drives NSC differentiation toward oligodendrocytes

University of Zurich professor recognized with 2015 Vallee Young Investigator Award

New biosensors detect efficient microbial workers that produce chemical, pharmaceutical commodities

Vaccine containing virus-like nanoparticles could be novel treatment option for RSV

Scientists produce functional liver cells from human embryonic and genetic engineered stem cells

Researchers uncover master regulators that govern the fate of TFH cells

Novel 3D human skin tissue model could help detect presence of known skin sensitizers in medical device extracts

New study reports creation of genetic porcine model of cancer

Study: GMO labeling would not scare consumers from buying food products with GMO ingredients

New type of mycovirus can cause aspergillosis in humans

Researchers develop dynamic functional mouse model for lung injury repair

Innovative approach to treating AAT deficiency

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo